@article{6ba59db7efcf4ced8fe8b24fa1e17a62,
title = "Strengthening accrual to cancer clinical trials",
author = "Trimble, {Edward L.} and Denicoff, {Andrea M.} and Abrams, {Jeffrey S.}",
note = "Funding Information: The National Cancer Institute (NCI)'s strong commitment to prospective clinical trials dates to 1955, when the US Congress established the National Cancer Chemotherapy Service Center, prompted by oncologists and patient advocates, led by Dr. Sidney Farber and Mrs. Mary Lasker. The NCI now supports clinical trials through 12 multi-institutional cooperative groups, 58 clinical and comprehensive cancer centers, 67 Specialized Programs of Research Excellence, and a variety of consortia, grants, and contracts. Recent initiatives by the NCI, working with partners in academia, industry, and the advocacy community, to strengthen the NCI's clinical trials system have included efforts to shorten the times for protocol development and speed trial accrual, with the ultimate goal to get improved cancer treatments to patients sooner [1] . ",
year = "2010",
month = mar,
doi = "10.1016/j.ygyno.2010.01.015",
language = "English (US)",
volume = "116",
pages = "291--292",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",
}